Canine Electrocardiography: Interpretation of Common Arrhythmias

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• The systematic interpretation of canine electrocardiograms (ECGs) begins with confirming recording quality and calibration, followed by assessment of heart rate, P wave presence and relationship to QRS complexes, R-R interval regularity, QRS morphology, and key interval measurements (PR, QT).
• Common arrhythmias in dogs include sinus arrhythmia (physiologic, vagally mediated), atrial fibrillation (irregularly irregular rhythm, no P waves, narrow QRS, associated with structural heart disease), and ventricular premature complexes (wide, bizarre QRS, no preceding P wave, significance dependent on frequency and underlying disease).
• Arrhythmias arise from abnormal automaticity, triggered activity (afterdepolarizations), or reentry circuits requiring unidirectional block and slowed conduction, with canine substrates including AV accessory pathways and ventricular scar.
• The primary discriminator between supraventricular and ventricular arrhythmias is QRS duration; narrow QRS complexes suggest supraventricular origin, while wide, bizarre complexes indicate ventricular origin, though aberrant conduction can complicate interpretation.
• Clinical significance and the need for intervention in canine arrhythmias are determined by hemodynamic impact, presence of underlying cardiac disease, and potential for degeneration into life-threatening rhythms, not solely by ECG findings.
• Drug-induced QT prolongation, a risk factor for torsades de pointes, is monitored via surface ECG, and its assessment in veterinary patients is informed by human drug-safety science principles, necessitating careful QT interval measurement and correction for heart rate.

This reference provides a systematic framework for interpreting electrocardiograms (ECGs) in dogs, with emphasis on the arrhythmias most frequently encountered in general and referral practice. The content is directed at veterinary students and practitioners who have mastered basic ECG acquisition and seek a structured approach to rhythm diagnosis. The article focuses on recognition, mechanistic understanding, and clinical decision-making for common supraventricular and ventricular arrhythmias, and it deliberately excludes advanced electrophysiologic mapping and ablation techniques.

The reader is assumed to understand normal canine cardiac conduction, lead systems, and waveform morphology. This article builds on that foundation to address the interpretive challenges that arise when rhythm disturbances are present. The diagnostic reasoning presented here applies to the dog as a species, where findings differ meaningfully from other species, those differences are noted explicitly.

At a Glance

Electrophysiologic Basis for Arrhythmia Generation

Arrhythmias arise from one of three fundamental mechanisms: abnormal automaticity, triggered activity, or reentry. Abnormal automaticity occurs when cells outside the primary pacemaker depolarize spontaneously and reach threshold before the sinus node. Triggered activity depends on afterdepolarizations, which are oscillations in membrane potential that occur during (early afterdepolarizations) or after (delayed afterdepolarizations) repolarization. Early afterdepolarizations are particularly relevant to drug-induced QT prolongation and torsades de pointes, as described in the consensus statement on drug-induced torsades by the Independent Academic Task Force, which outlines how surface ECG changes reflect underlying ion channel effects Fenichel et al., drug-induced torsades de pointes consensus.

Reentry requires a circuit with unidirectional block and slowed conduction, allowing an impulse to re-excite tissue that has already repolarized. The interaction between the electrical source and the surrounding myocardial load determines whether a reentrant wavefront propagates or extinguishes. Pathologic remodeling, such as fibrosis or ischemia, alters this source-load relationship and creates substrates that favor reentry, as reviewed in the context of electrocardiographic imaging of arrhythmogenic substrates Rudy, noninvasive electrocardiographic imaging. In dogs, common reentrant substrates include atrioventricular accessory pathways and ventricular scar from prior infarction or myocarditis.

Action Potential Phases and Surface ECG Correlates

The surface ECG reflects the summation of individual action potentials across the myocardium. The P wave corresponds to atrial depolarization, the PR interval to atrioventricular nodal conduction, the QRS complex to ventricular depolarization, and the T wave to ventricular repolarization. The QT interval encompasses the entire ventricular action potential duration. Prolongation of the QT interval indicates delayed repolarization and increases vulnerability to early afterdepolarizations and polymorphic ventricular tachycardia. This relationship is well established in human drug-safety science, where surface ECG monitoring remains the primary screening tool for repolarization risk Fenichel et al., drug-induced torsades de pointes consensus.

Systematic Approach to Rhythm Interpretation

A consistent interpretive sequence reduces diagnostic error. Begin by confirming the recording quality and calibration. Measure the heart rate, then examine the rhythm strip for the presence and morphology of P waves. Determine whether every P wave is followed by a QRS complex and whether every QRS complex is preceded by a P wave. Assess the regularity of the R-R intervals. Finally, evaluate QRS morphology and width, and measure the PR and QT intervals.

This sequence distinguishes the major arrhythmia categories: sinus node dysfunction, atrial arrhythmias, junctional rhythms, and ventricular arrhythmias. The differential diagnosis narrows substantially once the P-to-QRS relationship is established.

Rate and Rhythm Assessment

The normal canine heart rate varies with breed, age, and body size. Sinus arrhythmia, characterized by phasic variation in R-R intervals that correlates with respiration, is a normal finding in dogs and reflects high vagal tone. The absence of sinus arrhythmia in a dog with respiratory sinus arrhythmia at rest may indicate autonomic dysfunction or cardiac disease.

Sinus Node Arrhythmias

Sinus arrhythmia is the most common rhythm in healthy dogs and requires no treatment. Sinus bradycardia, defined as a sinus rate below the normal range for the patient, may be physiologic in athletic breeds or pathologic in conditions such as hypothyroidism, increased intracranial pressure, or drug administration. Sinus tachycardia exceeds the normal range and occurs with pain, fever, hypovolemia, or sympathetic stimulation.

Sick sinus syndrome deserves particular attention in dogs. It is characterized by inappropriate sinus bradycardia, sinus arrest, and alternating bradyarrhythmias and tachyarrhythmias. The condition is most commonly recognized in miniature schnauzers and other small breeds. Diagnosis requires documentation of the arrhythmia on ECG, often with prolonged ambulatory monitoring when clinical signs are intermittent.

Atrial Arrhythmias

Atrial premature complexes arise from ectopic foci within the atria and appear as early P waves with morphology different from the sinus P wave. The QRS complex that follows is typically narrow and normal in configuration because ventricular depolarization proceeds through the normal conduction system. Atrial premature complexes may conduct normally or with aberrancy, and the resulting QRS widening can be mistaken for a ventricular arrhythmia.

Atrial fibrillation is the most clinically significant atrial arrhythmia in dogs. The ECG shows an irregularly irregular ventricular response, absence of P waves, and fibrillatory waves that may be subtle or absent. The ventricular rate depends on the conduction properties of the atrioventricular node and the autonomic state of the patient. Atrial fibrillation in dogs is almost always associated with underlying structural heart disease, most commonly myxomatous mitral valve disease or dilated cardiomyopathy. The irregularly irregular rhythm is diagnostic, but a rapid ventricular response can make the irregularity less obvious, and careful measurement of consecutive R-R intervals is required.

Ventricular Arrhythmias

Ventricular premature complexes (VPCs) originate below the atrioventricular node and produce wide, bizarre QRS complexes that are not preceded by P waves. The T wave typically points opposite to the main QRS deflection. VPCs may occur as isolated events, in bigeminy or trigeminy patterns, or in runs of ventricular tachycardia. The clinical significance of VPCs depends on their frequency, complexity, and the presence of underlying cardiac disease.

Ventricular tachycardia is defined as three or more consecutive VPCs at a rate exceeding the normal ventricular rate. It may be monomorphic or polymorphic, and the distinction has prognostic and therapeutic implications. Polymorphic ventricular tachycardia, particularly the torsades de pointes pattern associated with QT prolongation, requires immediate attention because it can degenerate into ventricular fibrillation Fenichel et al., drug-induced torsades de pointes consensus. The management of ventricular arrhythmias in dogs follows principles similar to those outlined for human patients in the global consensus statement on catheter ablation of ventricular arrhythmias, though the procedural options differ substantially between species Cronin et al., expert consensus on catheter ablation of ventricular arrhythmias.

Step-by-Step ECG Interpretation Checklist

A consistent sequence reduces the risk of missing a clinically significant finding. Work through the following steps in order on every tracing, regardless of how obvious the dominant rhythm appears.

1. Confirm the recording. Check lead labels, paper speed (typically 25 or 50 mm/s), and calibration (usually 10 mm/mV). A mislabeled lead or incorrect speed invalidates interval measurements.
2. Identify the underlying rhythm. Scan the entire strip for P waves. Determine whether each P wave is followed by a QRS complex and whether the morphology is consistent.
3. Measure the ventricular rate. Count QRS complexes over a fixed time window and convert to beats per minute. Use the same window for atrial rate if P waves are visible.
4. Assess rhythm regularity. Measure R-R intervals across consecutive beats. Variation of less than 10% is generally considered regular.
5. Evaluate P waves. Assess presence, morphology, and axis. Note whether P waves precede every QRS and whether the P-R interval is constant.
6. Measure the P-R interval. Normal canine P-R interval is 0.06 to 0.13 seconds. Prolongation suggests AV nodal conduction delay.
7. Measure the QRS duration. Normal canine QRS duration is 0.04 to 0.06 seconds. Widening indicates ventricular origin or intraventricular conduction disturbance.
8. Assess QRS morphology. Note amplitude, notching, and axis deviation. Compare complexes across leads.
9. Evaluate the ST segment and T waves. Look for elevation, depression, or T wave polarity changes relative to the QRS.
10. Measure the QT interval. Correct for heart rate. Prolongation is relevant when assessing drug effects or electrolyte disturbances.
11. Search for ectopic complexes. Identify premature beats, pauses, or escape complexes. Classify each by origin and timing.
12. Document the interpretation. Record the rhythm diagnosis, rate, intervals, and any abnormalities in the medical record with the strip attached.

Decision Points in Arrhythmia Classification

The first decision is whether the arrhythmia is supraventricular or ventricular in origin. QRS duration is the primary discriminator. A narrow QRS with normal morphology indicates supraventricular origin, while a wide, bizarre QRS suggests ventricular origin. Exceptions exist, including aberrant conduction and pre-excitation, but these are uncommon in dogs.

The second decision is whether the arrhythmia is clinically significant. This depends on hemodynamic impact, the underlying cardiac disease, and the potential for degeneration into a more dangerous rhythm. A single premature ventricular complex in a young dog with no structural heart disease carries different weight than the same complex in a dog with dilated cardiomyopathy.

The third decision is whether intervention is required. This is guided by the patient's clinical status, not the electrocardiogram alone. A dog with syncope and sustained ventricular tachycardia requires treatment. The same rhythm in an asymptomatic dog with a normal echocardiogram may be monitored without antiarrhythmic therapy.

Arrhythmia Characteriztics and Clinical Significance

The following table summarizes the electrocardiographic features and clinical relevance of common canine arrhythmias.

Electrocardiographic Monitoring Parameters

Continuous ECG monitoring is indicated for dogs with syncope, suspected episodic arrhythmias, or those receiving antiarrhythmic therapy. The choice of monitoring modality depends on the clinical question and available equipment.

Heart rate variability analysis from Holter recordings provides additional prognostic information in dogs with myxomatous mitral valve disease and dilated cardiomyopathy, but its routine clinical use remains limited.

Documenting Electrocardiographic Findings

The medical record should contain the rhythm diagnosis, heart rate, and all measured intervals. Include a description of P wave morphology, QRS configuration, and ST segment changes. Note the lead system used and the paper speed. If antiarrhythmic therapy is initiated, document the indication, the drug and dose prescribed, and the planned monitoring interval.

Serial electrocardiograms are essential for assessing therapeutic response. Compare the current tracing to previous recordings instead of interpreting each in isolation. A change in QRS duration, arrhythmia frequency, or heart rate may indicate progression of disease or drug effect. The electrophysiologic mechanisms underlying drug-induced repolarization abnormalities, including torsades de pointes, are well characterized in human medicine and inform the monitoring approach for veterinary patients receiving drugs with QT-prolonging potential, as described in the consensus statement on drug-induced torsades de pointes.

When the Electrocardiogram Does Not Explain the Signs

A normal resting electrocardiogram does not exclude a paroxysmal arrhythmia. If the clinical history strongly suggests syncope or collapse of cardiac origin, proceed to ambulatory monitoring even when the in-hospital tracing is unremarkable. Conversely, an abnormal tracing does not always explain the presenting sign. Correlate the rhythm with the clinical episode whenever possible.

The interpretation of arrhythmogenic substrates has advanced considerably through noninvasive electrocardiographic imaging in human patients, as reviewed by Rudy on electrocardiographic imaging of arrhythmogenic substrates. These techniques remain research tools in veterinary medicine, but they highlight the importance of understanding the structural and functional context in which arrhythmias arise. A ventricular arrhythmia in a dog with echocardiographic evidence of myocardial disease carries different prognostic weight than the same arrhythmia in a structurally normal heart.

Recognized Complications and Failure Modes

The surface ECG fails to detect some arrhythmias because it samples only a brief window of cardiac electrical activity. Intermittent arrhythmias, including paroxysmal ventricular tachycardia and episodic atrial fibrillation, may be absent from a 60 second recording. Holter monitoring or event-triggered recording is indicated when syncope or collapse is episodic and the resting ECG is unremarkable.

Artifact is the most common false arrhythmia. Tremor, panting, and poor electrode contact produce baseline undulation that mimics atrial fibrillation or ventricular tachycardia. The discriminating feature is the absence of consistent QRS morphology and the presence of normal P waves and QRS complexes embedded within the artifact. Recheck electrode placement and reacquire the trace with the patient restrained and quiet.

Lead misplacement inverts the P wave and QRS complex in lead II, simulating an ectopic atrial or ventricular rhythm. Confirm that the right forelimb electrode is positioned at the right elbow and the left forelimb electrode at the left elbow. Compare the P wave axis across leads, a purely negative P wave in lead II with a normal heart rate and no clinical signs suggests lead reversal instead of a true arrhythmia.

Drug-induced QT prolongation is a recognized complication of antiarrhythmic therapy and certain non-cardiac drugs. The risk of torsades de pointes increases when the corrected QT interval exceeds a threshold that varies with the measurement method and the drug involved. The consensus of an independent academic task force on drug-induced torsades de pointes emphasizes that surface ECG monitoring during therapy is the primary screening tool for repolarisation abnormalities, and that QT interval changes should be interpreted in the context of the drug's known electrophysiologic profile Fenichel et al., drug-induced torsades de pointes consensus. Serial QT measurement is recommended when adding or adjusting drugs known to block the delayed rectifier potassium current.

Common Interpretation Errors and Corrections

Students commonly misclassify sinus arrhythmia as a pathologic bradyarrhythmia. Sinus arrhythmia in dogs is a normal respiratory-linked variation in heart rate, and the P wave morphology and PR interval remain constant. The corrective action is to measure the PR interval across several beats and to confirm that the rhythm variation tracks the respiratory cycle.

Another frequent error is diagnosing ventricular tachycardia when a rapid supraventricular rhythm conducts with aberrancy. The presence of a P wave preceding each QRS, even if buried in the preceding T wave, supports a supraventricular origin. Atrioventricular dissociation is the most reliable ECG sign of ventricular tachycardia, and its detection requires careful inspection of all leads for P waves that march through the QRS complexes. The global consensus statement on catheter ablation of ventricular arrhythmias notes that accurate arrhythmia localization and mechanism identification are prerequisites for appropriate therapy, and that misclassification leads to inappropriate drug selection Cronin et al., expert consensus on catheter ablation of ventricular arrhythmias.

Limitations of Current Evidence

The electrophysiologic mechanisms underlying canine arrhythmias are largely extrapolated from human studies and experimental animal models. The relationship between the source of electric activation and the load presented by cardiac tissue is altered in pathology, and remodelling processes create substrates that favour arrhythmia development, but the specific substrate characteriztics in canine myocardial disease are incompletely characterized Rudy, noninvasive electrocardiographic imaging of arrhythmogenic substrates. Expert opinion differs on the prognostic significance of ventricular ectopy in asymptomatic dogs with myxomatous mitral valve disease, and on the threshold for initiating antiarrhythmic therapy in dogs with frequent premature ventricular complexes but no hemodynamic compromise.

The J-wave syndromes, including Brugada syndrome and early repolarisation syndromes, are well described in humans but have no established canine equivalent Antzelevitch and Yan, J-wave syndromes. Clinicians should not apply human risk stratification criteria to dogs with J-point elevation or ST segment changes. The evidence base for canine-specific QT correction formulas is limited, and the choice of formula can change the clinical interpretation of a borderline QT interval.

Referral and Escalation Criteria

Referral to a veterinary cardiologist is warranted for sustained ventricular tachycardia, ventricular tachycardia with hemodynamic compromise, atrial fibrillation with a rapid ventricular response that is refractory to initial therapy, and high-grade atrioventricular block with syncope. Holter monitoring and echocardiography are indicated before initiating long-term antiarrhythmic therapy, because structural heart disease changes the risk-benefit balance of drug selection.

Laboratory involvement is required when electrolyte abnormalities are suspected. Hyperkalemia produces characteriztic ECG changes, including peaked T waves, widened QRS complexes, and loss of P waves, and these changes can be reversed with appropriate therapy. Serum potassium, magnesium, and ionised calcium should be measured in any dog with a new arrhythmia and a predisposing condition such as renal disease, gastrointestinal loss, or diuretic therapy.

Regulatory reporting is rarely required for canine arrhythmias. The WOAH terrestrial animal health standards address notifiable diseases and do not include arrhythmias as reportable conditions WOAH terrestrial animal health code. However, adverse drug reactions, including proarrhythmia attributed to a licensed veterinary product, should be reported to the relevant national pharmacovigilance scheme. The AVMA practice resources provide guidance on adverse event reporting obligations for veterinarians in the United States AVMA practice resources.

Frequently Asked Questions

How Do I Interpret an ECG When Only a Single-Lead or Poor-Quality Recording Is Available?

A single-lead tracing, typically lead II, remains adequate for rate, rhythm, and most interval measurements. Confirm the paper speed and calibration before measuring. If baseline drift or muscle artifact obscures P waves, increase the filter settings or reposition the electrodes. When the tracing is too noisy to assess P wave morphology reliably, repeat the recording instead of guess. For complex rhythms, a six-lead tracing improves your ability to localize ectopic foci and identify conduction patterns. The surface ECG has inherent limitations in resolving the three-dimensional activation sequence, and a poor recording compounds those limitations. If the rhythm remains ambiguous after a clean recording, treat the patient based on hemodynamic status and pursue referral.

What Should I Do When I Cannot Distinguish Supraventricular from Ventricular Premature Complexes?

Apply the clinical context first. A young dog with a structurally normal heart and a low burden of uniform complexes is more likely to have a supraventricular or benign ventricular origin. An older dog with syncope, collapse, or echocardiographic evidence of myocardial disease warrants a more cautious approach. Examine the QRS duration and morphology across multiple leads. A wide, bizarre QRS with a compensatory pause favours ventricular origin. Fusion beats and capture beats are diagnostic of ventricular complexes when present. If uncertainty persists, obtain a longer recording or a Holter monitor to capture the rhythm during clinical signs. The distinction matters for prognosis and therapy, but the immediate decision to treat depends on hemodynamic stability, not the precise origin of the complex.

How Do I Manage Arrhythmia Monitoring When Holter or Event Recording Is Not Available?

In-hospital telemetry or serial ECGs remain the practical alternative. Record a 2 to 3 minute ECG at presentation, then repeat at intervals dictated by the frequency of clinical signs. For intermittent arrhythmias, a 5 minute recording captures more events than a 1 minute strip. Train staff to record immediately after any observed episode of weakness or collapse. When the arrhythmia is exercise-induced, a post-exercise ECG can provoke the rhythm in some patients. If the clinical suspicion remains high and the ECG is unremarkable, document the negative finding and discuss referral for ambulatory monitoring. The absence of captured arrhythmia does not exclude a paroxysmal cause of syncope, and the diagnostic plan should reflect that uncertainty.

How Should I Explain an Arrhythmia Diagnosis to an Owner Who Is Anxious About Sudden Death?

Use concrete language that connects the ECG finding to the clinical picture. Explain that the heart has an electrical system that coordinates each beat, and that the ECG records that system. Describe the specific arrhythmia in terms the owner can understand, such as extra beats or pauses, and relate it to the signs they have observed. Avoid absolute prognostication. State what is known, what monitoring is planned, and what signs should prompt an immediate recheck. For dogs with ventricular arrhythmias and structural heart disease, acknowledge that the risk of sudden death exists but frame it within the treatment plan. The goal is an informed owner who can recognize deterioration without being paralysed by fear.

How Do I Decide Whether an Arrhythmia Requires Treatment or Can Be Monitored?

Base the decision on three factors: the hemodynamic impact, the underlying cardiac disease, and the arrhythmia's malignant potential. A dog with normal perfusion, no syncope, and a low burden of uniform ventricular complexes can often be monitored without antiarrhythmic therapy. Treatment is indicated for sustained tachyarrhythmias, arrhythmias associated with syncope or congestive heart failure, and high-grade ventricular ectopy in dogs with myocarditis or cardiomyopathy. The risk-to-benefit assessment of antiarrhythmic drugs is central to this decision. Drug-induced proarrhythmia, including torsades de pointes, is a recognized complication of pharmacotherapy, and the surface ECG is the primary tool for detecting repolarisation changes that predict this risk. Recheck the ECG after initiating therapy to document efficacy and monitor for adverse effects.

What Are the Key Differences in Arrhythmia Interpretation Between Dogs and Other Small Animals?

Cats have a higher resting heart rate and a shorter QT interval than dogs, and their P waves are smaller. Feline ventricular pre-excitation is rare, while hypertrophic cardiomyopathy dominates the arrhythmia profile. Atrial fibrillation in cats is uncommon and usually indicates advanced atrial disease. In dogs, sinus arrhythmia is physiologic and pronounced, whereas in cats it is less prominent and more often associated with systemic disease. The normal reference intervals for intervals and amplitudes differ between species, so use species-specific values. The electrophysiologic principles of re-entry, abnormal automaticity, and triggered activity apply across mammals, but the clinical expression and prognostic significance of specific arrhythmias vary substantially. Consult species-specific references when interpreting tracings from non-canine patients.

Related Clinical & Scientific Guides

• Canine Respiratory System: Anatomy and Physiology
• Comparative Anatomy of the Mammalian Kidney
• Feline Cardiopulmonary Physiology: Heart-Lung Interactions

References and Further Reading

• Drug-induced torsades de pointes and implications for drug development.. 2004.
• Noninvasive electrocardiographic imaging of arrhythmogenic substrates in humans.. 2013.
• 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.. 2019.
• Techniques for automated local activation time annotation and conduction velocity estimation in cardiac mapping.. 2015.
• J-wave syndromes: Brugada and early repolarization syndromes.. 2015.
• Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.. 2011.
• NCBI Bookshelf: Veterinary and Comparative Biomedical Sciences. NCBI Bookshelf.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Canine Cardiac Physiology: Electrical Conduction and Arrhythmias
• Canine Liver Anatomy and Lobular Structure
• Canine Lymphatic System: Anatomy and Function
• Canine Respiratory System: Anatomy and Physiology
• Canine Endocrine Physiology: Hypothalamic-Pituitary Axis

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.